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A B ST R AC T  
 
Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclusion 
of cervical biopsy for diagnostic purposes in cases whereas there is no pathological finding in 
colposcopy. In this study, we aimed to investigate the effect of simultaneous routine cervical biopsy 
in patients with normal colposcopic findings on the rate of cervical intraepithelial neoplasia diagnosis.  
Methods: This retrospective study included 119 patients with colposcopy indications who had no 
cervical pathology between January 2015 and March 2017 and the histopathological results were 
evaluated. 
Results: The mean age of the population was 45.75±9.52 years. The histopathological results 
obtained in our study patients are as follows; 38.7% (n=46) LSIL, 28.7% (n=33) chronic cervicitis, 
15, 3 % (n=19) coilositosis, 9.2% (n=11) HSIL, 2.5% (n=5) adenocarcinoma, 1.7% (n=2) carcinoma 
in situ and 2.1% (n=3) squamous carcinoma. LSIL 33 (27.5%), HSIL and advanced lesion 11 (9.2%) 
were detected in patients with normal cervical cytology before colposcopy. LSIL 26 (21.7%), HSIL 
and advanced lesion were found to be 13 (10.8%) in patients with abnormal cervical cytology. There 
was no significant difference in terms of biopsy pathology results between normal and abnormal 
cervical cytology results. 
Conclusions: In patients with HPV positive and normal colposcopic findings, adding simultaneous 
routine four-quadrant cervical biopsy to the colposcopy might increase the detection rate of cervical 
intraepithelial lesions. 
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Introduction 
Cervix cancer is the second most frequent 
cancer among women cancers in developing 
countries after breast cancer [1,2]. "National 
Standards of Cervical Cancer Screening" was 
published by the Ministry of Health in Turkey 
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in 2007. In a community-based screening 
program to be conducted in Turkey, it is 
recommended to sample smear on all women 
between the ages 35-40 years old at least once 
and to repeat in every five years and terminate 
at the age of 65 years old if the previous two 
test results are negative [3].  The development 
of cervical cancer on a background of 
dysplasia and the possibility of the early 
diagnosis of these lesions during the dysplasia 
stage with screening tests is an essential 
advantage for the early diagnosis of this fatal 
malignancy [4]. According to the statistical 
analysis of the data verified from the Turkey 
Ministry of Health  Cancer Department, the 
prevalence of cervical cancer is  0,004%, 
which was previously reported as 0,0045% at 
2000 [5].  According to these data, the 
adequate conduction of the screening programs 
on the selected population decreases the 
prevalence of the malignancy by 25% and the 
mortality by 35% [6]. Cervical cancer is the 
overall second most common cancer among 
women and 50.000 new cases per year are 
reported, and 250.000 women die every year 
from this cause [7].  According to ALTS 
(ASCUS-LSIL Triage Study), colposcopy and 
colposcopic biopsy are recommended on 
patients with LGSIL and HGSIL smear result 
[8]. The data about the dysplasia ratios on the 
follow up of ASCUS cases and cases with 
benign (inflammation, etc.) smear results are 
limited in our country [8]. According to the 
Guide of American Cancer Society, published 
in 2012, in addition to cytology (Pap test), 
HPV DNA test has prioritized [9]. 50% of 
women diagnosed with cervical cancer have 
never been screened previously, and only 10% 
have been screened for cervical cancer in the 
last five years [9]. Colposcopy is used for 
clarification of the cytological diagnosis by 
identification of the lesions localization and 
size and treatment management [10]. Although 
the treatment options are specified when High-
grade lesions are detected, management of 
low-grade lesions is still controversial [11]. 
While the effect of treatment of low-grade 
lesions on the incidence of cervical cancer has 
not yet been decisive, the necessity of invasive 
methods such as colposcopy and biopsy used 
in the management of these lesions and the 
cost-effectiveness are still controversial 
[12,13]. There are also publications in the 
literature reporting that colposcopy could miss 
30-55% of the high-grade lesions like CIN II 
and above [14,15,16]. Therefore, it is argued 
that random cervical biopsies in patients with 
high-grade Pap smear results may reveal CIN 
II and higher graded lesions that may be 
unnoticed via colposcopy [11,12]. 
This study aimed to investigate the efficiency 
of routine four quadrants cervical punch 
biopsy in the diagnosis of cervical 
intraepithelial neoplasms in patients with 
normal colposcopic findings. 
 
Methods 
This study is designed as a retrospective case 
study. This study was carried out with the 
approval of the ethics committee of the Bolu 
Abant Izzet Baysal University clinical 
researches (Decision no: 2017/72). Among 
gynecology outpatient patients between 
January 2015 – March 2017, who had a 
colposcopic examination, those with no 
abnormal colposcopic findings were included 
in the study. Colposcopy indications include 
HPV 16 or 18 positivity independent of smear 
result, ASCUS with any type of HPV 
positivity, all kinds of epithelial cell 
abnormalities from ASCUS, recurrent 
inadequate cytology and gross lesion in the 
cervix. A total of 119 patients aged between 
26-67 years were evaluated.  
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Patients’ files were scanned retrospectively, 
and for the missing information, the patients 
were reached by phone. Colposcopy 
indications include HPV 16 or 18 positivity 
independent of smear result, ASCUS with any 
type of HPV positivity, all kinds of epithelial 
cell abnormalities from ASCUS, recurrent 
inadequate cytology and gross lesion in the 
cervix.  
Patients with a history of previous cervical 
surgery and cervical pre-invasive/ invasive 
lesion, pregnant, and hysterectomy were 
excluded from the study. 
At least two days of sexual absence were 
required for all the patients included in the 
study. The colposcopic evaluation was 
performed in the follicular phase. Colposcopic 
examinations were performed with a 40X 
zoom, green filtered, Carl Zeiss brand 
binocular colposcope. The colposcopic 
examination was assessed as adequate when 
the cervix was fully observed, the 
squamocolumnar junction was completely 
visible, and there were no severe inflammation 
or atrophy. During the colposcopic 
examination, the presence of any suspicious 
areas on the cervix was assessed by 5% acetic 
acid staining, and subsequently by Lugol 
staining (Schiller test). The green light 
examination was used to assess the presence of 
any abnormal vascularity. Abnormal 
colposcopic findings such as aceto-white 
epithelium, punctuation, mosaicism, 
leukoplakia, and atypical vascular structures 
were evaluated. In our study, patients with 
adequate colposcopy and none of these 
abnormal findings were included. In patients 
with normal colposcopic findings, routine 
random punch biopsies were taken from four 
quadrants of the cervix, and the specimens 
were sent for histopathological examination.  
In our clinic, it is routine to obtain four 
quadrants cervical biopsy even if there is no 
abnormal finding, and this is also in 
accordance with ASCCP.  
Biopsy samples were dehydrated with ethanol 
solution after being kept in 10% formaldehyde 
solution overnight. Then the biopsy specimens 
were washed with xylene and buried in 
paraffin blocks. 4 mm thick section cuts were 
taken. With the help of a light microscope, a 
histopathologic examination was performed 
under the magnification of 20 x and 40 x. 
Cervical smear and biopsy findings were 
compared. Pathology reports were grouped as 
abnormal (CIN I, CINII-III, invasive 
carcinoma) and normal (cervicitis, metaplasia, 
cervical, and others) findings. Cervical smear 
results and histopathological results were 
evaluated retrospectively. 
 
Statistical analysis  
SPSS (Statistical Package for Social Sciences) 
version 18.0 (SPSS Inc. USA) is used for 
statistical analysis. One - sample test and Chi-
Square tests are used for interpreting data. Test 
results are assessed within 95% confidence 
interval and statistical significance is 
considered if p<0.05. 
 
Results  
The cervical cytology and histopathology 
results of 119 patients with normal colposcopic 
findings were retrospectively examined. This 
study initially included 119 patients. All of 
patients' colposcopy examinations were 
adequate.  
When the demographic characteristics of the 
patients were examined, the mean age was 
45.75±9.52 years (44.04 - 47.47, 95% CI), 
mean gravida was 2.44±1.79 (2.12 - 2.77, 95% 
CI), mean parity was 2.06±1.44 (1.80 - 2.32, 
95% CI).  
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According to HPV-DNA results of the cases 
(Table 1); 35.5% (n=42) of the cases had HPV-
16 positivity, 8.4% (n=10) had HPV-18 
positivity, 32.8% (n=39) had other types of 
HPV positivity, 4.2% (n=5) had both HPV 16 
and18 positivity, 7.6% (n=9) had HPV 16 and 
other types, 1.7% (n=2) had HPV16-18 and 
other types positivity , 1.7% (n=2) had 
negative for HPV, 7.6% (n=9) had unknown 
HPV types and 0.8(n=1) had HPV18 and other 
types positive. 
 
Table 1. Types of HPV-DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution of pathology results according to 
HPV results were shown in table 2. The 
pathology results of HPV 16 positive patients 
were as follows; 10% (n=12) LSIL, 12, 6% 
(n=15) chronic cervicitis, 6,8% (n = 8) HSIL, 
0,9% (n=1) invasive squamous carcinoma and 
5% (n=6) coilositosis. When the HPV18 
positive patients were evaluated  7,6% (n=9) 
had LSIL and 0,9% (n=1) had carcinoma in 
situ and HPV 16-18 positive patients were 
evaluated 3,4% (n=4) had LSIL and 0,9% 
(n=1) had carcinoma in situ, The pathology 
results of HPV other types positive 6,8% (n=8) 
had LSIL, 2,5% (n=3) had HSIL, 2,5% (n=3) 
had adenocarcinoma, 5% (n=6) coilositosis, 
11,8 (n=14) chronic cervicitis and 0,9% (n=1) 
invasive squamous carcinoma. HPV 16 and 
other positive patients were evaluated 6,8% 
(n=8) had LSIL, 1% (n=1) had chronic 
cervicitis. HPV 18 and other positive patients 
were evaluated 0, 9% (n=1) invasive squamous 
carcinoma and HPV 16-18 and others 
positivity histopathological results were 1, 7% 
(n=2) adenocarcinoma and unknown HPV 
results were 0, 9% (n=1) LSIL, 6 % (n=7) 
coilositosis and 0.9% (n=1) chronic cervicitis, 
HPV negative results were 1.7% (n=2) chronic 
cervicitis. 
 
Table 2. Distribution of pathology results 
according to HPV results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to the cervical cytology results of 
the examined cases (Table 3), 29.4% (n = 35) 
had normal findings, 17.6% (n=21) had  
infection, 16% (n=19) had ASCUS, 3.4% 
(n=4) had ASC-H, 8.4% (n=10) had 
insufficient, 18,4%(n=22) had LSIL, 5.04% 
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(n=6) unknown smear results, 0.9% (n=1)  had 
AGUS, and 0.9% (n=1) had AGS. 
 
Table 3. Distribution of cytology results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thirty three patients (27.5%) had CIN-I, and 
five patients (4.2%) had CIN II-III at 
histopathology. Smear results of the five 
patients with CIN II and III were reported as 
infection. When the HPV DNA results of these 
patients were compared, 1.7% (n = 2) had HPV 
16 positivity, 2.4% (n=3) had HPV 16 and 18 
positivity. 
Distribution of smear results according to 
pathology results were shown in table 4. When 
the pathology result of the patients who 
presented LSIL as results of smear had  4,2% 
(n=5) LSIL, 1,7% (n=2) had HSIL, 0,9% (n=1) 
had squamous carcinoma, 5% (n=6) had 
chronic cervicitis, 6,8% (n=8) had coilositosis, 
ASCUS as results of smear had 6,8% (n=8) 
LSIL, 1,7% (n=2) had HSIL, 0,9% (n=1) had 
adenocarcinoma, 0,9%(n=1) had carcinoma in 
situ, 0,9% (n=1) had squamous carcinoma 3,4 
% (n=4) had chronic cervicitis, 1,7%(n=2) had 
coilositosis and the pathology result of the 
patients who presented ASH as results of 
smears had 1,7% (n=2) LSIL, had 1,7% (n=2) 
chronic cervicitis. Smear results were normally 
distributed in 11,8% (n=14) had LSIL, 2,1% 
(n=3) had HSIL, 0,9% (n=1) had carcinoma in 
situ, 0,9% (n=1) had adenocarcinoma,10% 
(n=12) had chronic cervicitis, 3,4% (n=4) had 
coilositosis. Then smear results were infection 
distributed in 10% (n=12) had LSIL, 0,9% 
(n=1) had HSIL, 0,9% (n=1) had 
adenocarcinoma, 5% (n=6) had chronic 
cervicitis, 0,9% (n=1) coilositosis. The 
pathology of the patient with smear result AGC 
0, 9 (n=1) had LSIL and results of AGUS had 
0, 9% (n=1) had adenocarcinoma. 
The result of the unknown smear results were 
0, 9% (n=1) LSIL, 0, 9% (n=1) HSIL, 0, 9% 
(n=1) chronic cervicitis, 1,7% (n=2) 
coilositosis. Insufficient material of smear 
results according to pathology result were 2, 
1% (n=3) LSIL, 1, 7% (n=2) HSIL, 0,9% (n=1) 
adenocarcinoma, 0,9% (n=1) squamous 
carcinoma and 1,7% (n=2) chronic cervicitis, 
1,7% (n=2) coilositosis. 
 
Table 4. Distribution of smear results according to 
pathology results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The histopathological results obtained in our 
study patients are as follows; 38.7% (n=46) 
LSIL, 28.7% (n=33) chronic cervicitis, 15, 3% 
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(n=19) coilositosis, 9.2% (n=11) HSIL, 4,2% 
(n=5) adenocarcinoma, 1.7% (n=2) carcinoma 
in situ and 2.1% (n=3) squamous carcinoma 
(Table 5). 
 
Table 5. Distribution of four-quadrant cervical 
biopsy results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
When the pathological diagnosis were 
examined according to age groups, the highest 
frequency was in between the ages of 46-55 
years.  The most common pathology 
encountered in this age group was LSIL and 
chronic cervicitis. In the 46-55 age group 
population, LSIL was 13.4% (n=16), and 
chronic cervicitis was 9.2% (n=11). In 25-35 
age group, 5.9% (n=7) had chronic cervicitis, 
9.2% (n=11) had LSIL, 1.7% (n=2) had HSIL 
and 1.7% (n=2) had carcinoma in situ. In the 
36-45 age group, 11.8% (n=14) had chronic 
cervicitis, 15.1% (n=18) had LSIL, 1.7% (n=2) 
had HSIL, 1.7% (n=2) had invasive squamous 
carcinoma. 
In the 46-55 year age group, 4.2% (n=5) had 
chronic cervicitis, 13.4% (n=16) had LSIL, 
3.4% (4) had HSIL. When the group of 56 
years of age and above was examined, 4.2% 
(n=5) had chronic cervicitis, 9.2% (n=11) had 
LSIL, 1.7% (n=2), 2.5% (n=3) had HSIL. The 
diagnosis of carcinoma did not increase with 
the increased age and no significant 
differences were found. 
The cytology results were evaluated as non-
pathological when the findings were normal or 
infectious. 35 of the smear results were normal, 
10 were insufficient material and 21 were 
infections. When the cytology and 
histopathology results were compared (Table 
7),   we saw that, of the 65 (54.2%) patients 
with normal smear results. 54 (45.8%) smear 
results were pathologic-abnormal smear 
results. LSIL 33 (27.5%), HSIL and advanced 
lesion 11 (9.2%) were detected in patients with 
normal cervical cytology before colposcopy. 
LSIL 26 (21.7%), HSIL and advanced lesion 
were found to be 13 (10.8%) in patients with 
abnormal cervical cytology. There was no 
significant difference in terms of biopsy 
pathology results between normal and non-
normal cervical cytology results (p=0.655). 
 
Table 6. Comparison of biopsy pathology results 
between normal and pathological smear results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
In this article, the histopathological diagnoses 
of patients who were referred to colposcopy 
                                                        Cetin et al.  Exp Biomed Res 2019; 2(3):111-120 
   
 
117 
 
due to various indications are examined by 
concerning both smear and colposcopy results, 
and it was found that four quadrant biopsy can 
increase the sensitivity of colposcopy. Our 
study is shown that in patients with high-risk 
HPV DNA positivity, the diagnose rate of pre-
invasive and invasive cancer could be 
increased 20, 2% with 4-quadrant cervical 
biopsy application in addition to colposcopy. 
According to the ASCCP guide, CIN was 
detected in 17,2% of patients with a routine 
four-quadrant cervical biopsy, with the 
addition of a normal to a biopsy of the patient 
without any pathological findings to be 
diagnosed with colposcopy. Gage et al. among 
the analytical group of 2675 women with 
adequate enrollment colposcopically guided 
biopsy results, the 2-year cumulative risk for 
Pathology Quality Control Group histology 
diagnosis of CIN 3 at any time during ALTS 
was 15.3% [17]. 
Community-based screening programs have 
high importance in preventing cervical 
neoplasia. The diagnosis of asymptomatic pre-
invasive lesions resulted in a significant 
decrease in the mortality and morbidity of the 
disease as a result of early intervention [6,18]. 
Most of the low-grade cytological 
abnormalities are known to regress 
spontaneously; however, one-third of the 
patients with a biopsy result of high-grade 
cervical intraepithelial neoplasia (CIN) is 
known to be reported as ASCUS in cytology 
[19,20]. In this study, the rate of patients who 
had ASCUS in cytology and subsequently CIN 
II-III in pathological biopsy was found as 10%. 
These ratios were consistent with the results of 
the ALTS (ASCUS/LSIL Triage Study) study 
(11.4 %) [8]. 
Dogan et al. [21] analyzed the prognostic value 
of HPV genotypes in cervical cancer in their 
large retrospective study. They reported that 
HPV-18-associated tumors frequently had 
earlier relapse than HPV-16, and 
adenocarcinoma was preferentially related to 
HPV-18 and therefore HPV 18 was more 
aggressive than HPV 16. Our study revealed 
HPV 16 positive patients had the following 
pathological diagnoses; 6.2% (n=8) HSIL, 
0.9% (n=1) invasive squamous carcinoma. 
When HPV 18 positive patients were 
evaluated; 7,6% (n=9) had LSIL and 0.9% 
(n=1) had carcinoma in-situ. Our findings are 
inadequate either to support or refuse the 
findings of this study. 
In the study by Tasdemir et al. [22]  random 
biopsies were performed on 49 patients whose 
colposcopy revealed no lesions, and results 
showed that one patient had CIN 3, and two 
patients had CIN2.  Those three patients 
consisted of %6,1 of the negative colposcopy 
patients.  
In the present study, CIN II-III was diagnosed 
with four-quadrant cervical biopsy in 11 
patients (9.6%). This rate is consistent with the 
study of Tasdemir et al. [22] when their 
relatively smaller cohort size is taken into 
consideration. Therefore, in various studies, it 
is argued that random biopsies in patients with 
normal colposcopic findings can capture the 
lesions of CIN II and above, particularly in 
those with a high-grade Pap smear result 
[16,19]. 
In a study with 2825 patients conducted by 
Massad et al. [14], the specificity of 
colposcopy for CIN II -III was found as 52%. 
The sensitivity for the CIN II-III was found to 
be higher, like 58%. The specificity of 
colposcopy was below 60%, which came with 
high false positivity rates. False negativity 
ranged from 20-40%. However, colposcopy is 
known to have high sensitivity in HGSIL 
detection [15,16]. In this study, the sensitivity 
of colposcopy was not evaluated because 
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colposcopy positive patients were not included 
in the study. Intraepithelial lesion was 
identified in 10% of the patients with normal 
colposcopy results by adding a routine 
simultaneous cervical biopsy. According to 
these preliminary results, we believe that 
colposcopy may have a lower sensitivity 
without a routine cervical biopsy. 
Since the aim of the screening programs is to 
identify CIN II and above lesions, we think that 
performing a cervical biopsy on patients with 
high-risk HPV will increase the sensitivity of 
colposcopy in the diagnosis of cervical 
cancers. 
When we categorize our patients according to 
age groups, we have reached the data that most 
of the patients were between 46-55 years of 
age. We think that this was due to the routine 
application of cervicovaginal smears for the 
last ten years in patients over 30 years of age 
which also resulted in a higher diagnoses rate 
in patients over 40 years of age. However, due 
to the low positive predictive value of 
screening tests, unnecessary interventions can 
be performed. Also, the high false negativity 
rates of screening tests affect the reliability of 
these tests adversely; those rates are very 
valuable because they are the simplest and the 
most commonly used tests that can be applied 
in a large number of patients. In a large study, 
353 patients were evaluated according to the 
general colposcopic findings, and no random 
biopsies were performed from the four 
quadrants when there were no detectable 
abnormal findings [23]. They found the 
sensitivity and specificity of the general 
colposcopic findings as 63.8% and 88.8%, 
respectively. This study supports our work.  In 
the case of general colposcopy examination, 
there may not be any correlation between 
morphology and biopsy results.  
The study, including 195 patients who had 
colposcopy due to the atypical squamous cell 
by Patton et al. [24] found the risk of CIN II-
III as 6% after the age of 40 years. 
Consistently, our study found that 6, 2% of the 
patients aged over 40 years who underwent 
colposcopic examination due to various 
indications were diagnosed with CIN II-III.  
The non-inclusion of cases with positive 
colposcopic findings and the relatively low 
number of cases included in the study were the 
limitations of this study. However, this study 
was initially designed as a theoretical study. 
Assessing the sensitivity and specificity of 
colposcopy-guided biopsy results of our clinic 
was not primarily aimed. Since all patients in a 
given period were included in the study, it is 
assumed that the low number of patients can 
reflect the regional population. 
 
Conclusion 
Adding simultaneous routine four-quadrant 
cervical biopsy to the colposcopy might 
increase the detection rate of cervical 
intraepithelial lesions should be assessed in 
large randomized controlled trials. 
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